Establishment of a Lymphoma Registry in Brazil
Brazilian Network for Lymphoma Registry
Instituto Nacional de Cancer, Brazil · NCT02265497
This study is setting up a registry for lymphoma patients in Brazil to gather important information that can help improve diagnosis and treatment for the disease.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 550 (estimated) |
| Sex | All |
| Sponsor | Instituto Nacional de Cancer, Brazil (other gov) |
| Locations | 1 site (Rio de Janeiro, RJ) |
| Trial ID | NCT02265497 on ClinicalTrials.gov |
What this trial studies
This project aims to create a comprehensive registry for lymphoma patients across 12 Brazilian institutions, coordinated by the Brazilian National Cancer Institute. It will involve the development of a computerized system for collecting and managing demographic, clinical, epidemiological, histopathological, and molecular data related to lymphoma. By standardizing data entry and integrating local databases, the registry will provide valuable insights into the incidence, progression, and prognosis of lymphoma in Brazil, ultimately improving early diagnosis and treatment strategies.
Who should consider this trial
Good fit: Ideal candidates for this project include all patients, both adults and children, diagnosed with Hodgkin's or non-Hodgkin lymphoma who have available clinical and treatment data.
Not a fit: Patients with other types of cancer will not benefit from this study as it specifically focuses on lymphoma.
Why it matters
Potential benefit: If successful, this registry could enhance the understanding and management of lymphoma in Brazil, leading to improved patient outcomes.
How similar studies have performed: While similar registries have been established in other countries, this initiative is novel for Brazil and aims to fill a significant gap in lymphoma data.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * All patients (adult or child) with diagnosis of Hodgkin's or non-Hodgkin lymphoma with available with available clinical, histopathology and treatment data * Patient enrolled on study sites included on this project Exclusion Criteria: * Patients (adult or child) with other diagnoses of cancer
Where this trial is running
Rio de Janeiro, RJ
- Brazilian National Cancer Institute - INCA/ Ministry Of HealthClinical Research Department — Rio de Janeiro, RJ, Brazil (RECRUITING)
Study contacts
- Study coordinator: Claudio Gustavo Stefanoff, doctor
- Phone: +55 21 32076541
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Lymphoma